Posts by: Marisa Wexler

News

People with ulcerative colitis can be divided into groups based on gene expression, and this division can help identify those more likely to respond to treatments, a recent study ... Read more

July 16, 2019July 16, 2019

Study Links Etanercept with Increased IBD Risk

News

Treatment with etanercept may increase a person’s risk of developing inflammatory bowel disease (IBD), a study suggests. The study, “Increased risk of developing Crohn’s disease or ulcerative colitis in ... Read more

July 10, 2019July 10, 2019

Study Links Depression to Increased IBD Activity, Faulty Emotional Recognition

News

Depression is linked to increased disease activity and fewer positive emotional recognition biases in people with inflammatory bowel disease (IBD), a study suggests. The study, “Factors associated with depression ... Read more

June 28, 2019June 28, 2019

Sunshine May Lower Risk of IBD in Children, Study Suggests

News

Children who are exposed to more sunshine may be less likely to develop inflammatory bowel disease (IBD), a study suggests. The study, titled “Higher Sun Exposure is Associated With ... Read more

June 19, 2019June 19, 2019

Innovation Pharmaceuticals Signs Deal to Use Tablet Technology for Oral Brilacidin Treatment

News

Innovation Pharmaceuticals has signed an agreement to use OralogiK — an advanced tablet-coating technology patented by BDD Pharma — to develop tablets for targeted oral delivery of Brilacidin for ... Read more

June 17, 2019June 17, 2019

Nine-Month Results Show Continuing Efficacy of Abivax’s ABX464 in Extension Trial

News

Treatment with Abivax‘s ABX464 showed continuing effectiveness in ulcerative colitis patients, according to nine-month data of a maintenance clinical trial. The company is now recruiting people with moderate-to-severe ulcerative ... Read more